Guillain–Barré Syndrome Associated with SARS-CoV-2

Five patients who had Guillain–Barré syndrome 5 to 10 days after the onset of Covid-19 are described. Three had severe weakness and an axonal pattern on electrophysiological studies, and two had normal protein levels in the cerebrospinal fluid. The virus was not found in CSF.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The New England journal of medicine 2020-06, Vol.382 (26), p.2574-2576
Hauptverfasser:	Toscano, Gianpaolo, Palmerini, Francesco, Ravaglia, Sabrina, Ruiz, Luigi, Invernizzi, Paolo, Cuzzoni, M. Giovanna, Franciotta, Diego, Baldanti, Fausto, Daturi, Rossana, Postorino, Paolo, Cavallini, Anna, Micieli, Giuseppe
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Betacoronavirus Cerebrospinal fluid Coronavirus Infections - complications Coronavirus Infections - therapy Coronaviruses Correspondence COVID-19 Female Guillain-Barre syndrome Guillain-Barre Syndrome - etiology Humans Male Middle Aged Pandemics Patients Pneumonia, Viral - complications Pneumonia, Viral - therapy SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Ventilators Vital Capacity Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Five patients who had Guillain–Barré syndrome 5 to 10 days after the onset of Covid-19 are described. Three had severe weakness and an axonal pattern on electrophysiological studies, and two had normal protein levels in the cerebrospinal fluid. The virus was not found in CSF.
ISSN:	0028-4793 1533-4406
DOI:	10.1056/NEJMc2009191